A detailed history of Virtus ETF Advisers LLC transactions in Avidity Biosciences, Inc. stock. As of the latest transaction made, Virtus ETF Advisers LLC holds 2,305 shares of RNA stock, worth $65,208. This represents 0.05% of its overall portfolio holdings.

Number of Shares
2,305
Previous 2,265 1.77%
Holding current value
$65,208
Previous $92,000 14.13%
% of portfolio
0.05%
Previous 0.05%

Shares

16 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

BUY
$37.21 - $48.14 $1,488 - $1,925
40 Added 1.77%
2,305 $105,000
Q2 2024

Aug 14, 2024

SELL
$22.73 - $40.85 $193,750 - $348,205
-8,524 Reduced 79.01%
2,265 $92,000
Q1 2024

May 15, 2024

SELL
$9.16 - $25.52 $6,778 - $18,884
-740 Reduced 6.42%
10,789 $275,000
Q4 2023

Feb 15, 2024

BUY
$4.87 - $9.37 $16,635 - $32,007
3,416 Added 42.11%
11,529 $104,000
Q3 2023

Nov 07, 2023

SELL
$6.3 - $11.35 $5,084 - $9,159
-807 Reduced 9.05%
8,113 $51,000
Q2 2023

Aug 14, 2023

BUY
$10.62 - $17.34 $31,743 - $51,829
2,989 Added 50.4%
8,920 $98,000
Q1 2023

May 15, 2023

SELL
$15.35 - $25.65 $35,059 - $58,584
-2,284 Reduced 27.8%
5,931 $91,000
Q4 2022

Feb 14, 2023

SELL
$10.06 - $22.66 $6,408 - $14,434
-637 Reduced 7.2%
8,215 $182,000
Q3 2022

Nov 14, 2022

BUY
$15.46 - $23.43 $1,097 - $1,663
71 Added 0.81%
8,852 $145,000
Q2 2022

Aug 12, 2022

BUY
$11.18 - $20.5 $27,894 - $51,147
2,495 Added 39.69%
8,781 $128,000
Q1 2022

May 16, 2022

SELL
$14.2 - $23.78 $5,367 - $8,988
-378 Reduced 5.67%
6,286 $116,000
Q4 2021

Feb 14, 2022

SELL
$20.4 - $28.66 $31,109 - $43,706
-1,525 Reduced 18.62%
6,664 $158,000
Q3 2021

Nov 15, 2021

SELL
$18.16 - $25.21 $7,699 - $10,689
-424 Reduced 4.92%
8,189 $202,000
Q2 2021

Aug 10, 2021

SELL
$19.62 - $29.26 $10,300 - $15,361
-525 Reduced 5.75%
8,613 $213,000
Q1 2021

May 17, 2021

BUY
$20.28 - $28.15 $3,366 - $4,672
166 Added 1.85%
9,138 $199,000
Q4 2020

Feb 12, 2021

BUY
$24.73 - $35.12 $221,877 - $315,096
8,972 New
8,972 $229,000

Others Institutions Holding RNA

About Avidity Biosciences, Inc.


  • Ticker RNA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 52,127,000
  • Market Cap $1.47B
  • Description
  • Avidity Biosciences, Inc., a biopharmaceutical company, engages in the development of oligonucleotide-based therapies. It develops antibody oligonucleotide conjugates (AOC) that are designed to treat a range of serious diseases. The company's lead product candidate AOC 1001 is used for the treatment of myotonic dystrophy type 1, a rare monogenic...
More about RNA
Track This Portfolio

Track Virtus ETF Advisers LLC Portfolio

Follow Virtus ETF Advisers LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Virtus ETF Advisers LLC, based on Form 13F filings with the SEC.

News

Stay updated on Virtus ETF Advisers LLC with notifications on news.